| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 12/01/2010 | EP2256199A1 Therapeutic uses of BR43X2 soluble receptors |
| 12/01/2010 | EP2256115A1 Heteromonocyclic compound and use thereof |
| 12/01/2010 | EP2256114A1 Amide derivative and pharmaceutical composition containing the same |
| 12/01/2010 | EP2256109A1 Apoptosis inhibitor |
| 12/01/2010 | EP2256107A1 Amino-5-[4-(difluoromethoxy)phenyl]-5-phenylimidazolone compounds as inhibitors of the beta-secretase (BACE) |
| 12/01/2010 | EP2256106A1 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinases (CDK) and glycogen synthase kinase-3 (GSK-3) modulators |
| 12/01/2010 | EP2255848A2 Pharmaceutical combinations of a nicotine receptor modulator and a cognitive enhancer |
| 12/01/2010 | EP2255825A2 Composition for preventing or treating brain diseases |
| 12/01/2010 | EP2255812A1 Methods and compositions for reducing neurodegeneration in amyotrophic lateral sclerosis |
| 12/01/2010 | EP2255808A2 Opioids for the treatment of the restlessness of the lower limbs |
| 12/01/2010 | EP2255807A1 Method of treating sleep disorders using the combination of eplivanserin and zolpidem |
| 12/01/2010 | EP2255806A2 Fentanyl composition for nasal administration |
| 12/01/2010 | EP2255802A1 Adhesive skin patch and packaged product |
| 12/01/2010 | EP2255798A2 Sphingosine-1-phosphate receptor agonists for use in the treatment of optic neuritis |
| 12/01/2010 | EP2255668A2 Production and Use of a Polar Lipid-Rich Fraction Containing Omega-3 and/or Omega-6 Highly Unsaturated Fatty Acids from Microbes, Genetically Modified Plant Seeds and Marine Organisms |
| 12/01/2010 | EP2255667A1 Pasteurisation process for microbial cells and microbial oil |
| 12/01/2010 | EP2255666A1 Pasteurisation process for microbial cells and microbial oil |
| 12/01/2010 | EP2254884A2 3-alkyl-piperazine derivatives and uses thereof |
| 12/01/2010 | EP2254883A1 Substituted indole derivatives |
| 12/01/2010 | EP2254878A1 Aldh-2 inhibitors in the treatment of addiction |
| 12/01/2010 | EP2254876A1 Compound (r) -n*6*-ethyl-6, 7-dihydro-5h-indeno (5, 6- d) thiazole-2, 6-diamine and the use as antipsychotics |
| 12/01/2010 | EP2254870A2 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 |
| 12/01/2010 | EP2254869A2 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 |
| 12/01/2010 | EP2254865A1 Indole compounds and methods of use thereof |
| 12/01/2010 | EP2254864A1 Substituted 4-aminocyclohexane derivatives for the treatment of pain |
| 12/01/2010 | EP2254862A2 Azetidine-derived compounds, preparation method therefor and therapeutic use of same |
| 12/01/2010 | EP2254666A1 2-aminoquinolines as 5-ht5a receptor antagonists |
| 12/01/2010 | EP2254584A1 Biocompatible injectable products with zinc and/or zinc-form saccharide-salt release, and uses thereof |
| 12/01/2010 | EP2254580A1 Methods for treating disorders using nmda nr2b-subtype selective antagonist |
| 12/01/2010 | EP2254579A1 Use of compounds binding to the sigma receptor ligands for the treatment of neuropathic pain developing as a consequence of chemotherapy |
| 12/01/2010 | EP2254577A1 Ampa receptor antagonists for epilepsy, mental disorders or deficits in sensory organ |
| 12/01/2010 | EP2254567A2 Novel use of zinc n-acetyltaurinate |
| 12/01/2010 | EP2254564A1 Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline |
| 12/01/2010 | EP2254420A2 Cns pharmaceutical compositions and methods of use |
| 12/01/2010 | EP2254415A1 Aryl-hydroxyethylamino-pyrimidines and triazines as modulators of fatty acid amide hydrolase |
| 12/01/2010 | EP2254413A1 Imidazobenzazepine cgrp receptor antagonists |
| 12/01/2010 | EP2155179B1 Axomadol for treating pain from arthritis |
| 12/01/2010 | EP1926483B1 Treatment of autoimmune diseases |
| 12/01/2010 | EP1896467B1 Tricyclic opioid modulators |
| 12/01/2010 | EP1806141B1 Par-2 antagonists |
| 12/01/2010 | EP1765850B1 Substituted propane phosphinic acid derivatives |
| 12/01/2010 | EP1561807B1 Method of degrading hardly degradable protein |
| 12/01/2010 | EP1368342B3 Benzimidazole and pyridylimidazole derivatives as ligands for gaba receptors |
| 12/01/2010 | EP1244790B1 Nucleic acids encoding polypeptides having chips activity |
| 12/01/2010 | CN201658746U Moxibustion patch for insomnia |
| 12/01/2010 | CN201658128U Jasmine functional pillow with magnetic therapy |
| 12/01/2010 | CN1895387B Chinese medicine for treating mental retardation, tranquilization and promotion of growth |
| 12/01/2010 | CN1857237B New use of falcarindiol |
| 12/01/2010 | CN1853633B Use of beta-FNA in preparing medicine for dementia praecox treatment |
| 12/01/2010 | CN1847261B Cyclic peptides as g-protein-coupled receptor antagonists |
| 12/01/2010 | CN1750817B Use of the (1s, 2r) enantiomer of milnacipran for the preparation of a drug |
| 12/01/2010 | CN1520286B Gastric retention controlled drug delivery system |
| 12/01/2010 | CN101903372A Heteroaryl derivatives as orexin receptor antagonists |
| 12/01/2010 | CN101903364A Thiazolylidine urea and amide derivatives and methods of use thereof |
| 12/01/2010 | CN101903355A Novel imidazole-substituted arylamides |
| 12/01/2010 | CN101903349A 4-(4-pyridinyl)-benzamides and their use as ROCK activity modulators |
| 12/01/2010 | CN101903348A Novel pyrazole-substituted arylamides |
| 12/01/2010 | CN101903347A Piperidinyl and piperazinyl modulators of gamma-secretase |
| 12/01/2010 | CN101903342A Substituted N-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof as histamine H3 receptor modulators |
| 12/01/2010 | CN101903341A Substituted N-phenyl-bipyrrolidine ureas and therapeutic use thereof |
| 12/01/2010 | CN101903340A Substituted N-phenyl-bipyrrolidine carboxamides and therapeutic use thereof |
| 12/01/2010 | CN101903335A Amine linked modulators of gamma-secretase |
| 12/01/2010 | CN101903036A Active soluble post-translationally modified neuregulin isoforms |
| 12/01/2010 | CN101903021A Alpha-aminoamide derivatives useful in the treatment of psychiatric disorders |
| 12/01/2010 | CN101899466A Dengue virus and Japanese encephalitis virus embedded pseudo virus particle vaccine and preparation method thereof |
| 12/01/2010 | CN101899116A Non-invasive high-penetrability epidermal growth factor and application thereof |
| 12/01/2010 | CN101899074A Preparation method for monosialotetrahexosyl ganglioside and monosialotetrahexosyl ganglioside sodium injection or freeze-dried powder injection |
| 12/01/2010 | CN101899047A Beta-amino tetrahydropyrazine, tetrahydropyrimidine and tetrahydropyridine used as dipeptidy peptidase inhibitors for curing or preventing diabetes |
| 12/01/2010 | CN101898979A Phenyl nitrone compounds containing stilbene sections and application thereof |
| 12/01/2010 | CN101898977A GABA (Gamma-Aminobutyric Acid) conjugates and using method thereof |
| 12/01/2010 | CN101897970A Compositions and methods for treating diabetes |
| 12/01/2010 | CN101897964A Medicament for preventing autoimmune disease |
| 12/01/2010 | CN101897960A hNgR-Fc fusion protein vaccine for promoting regeneration and functional recovery of central nerves |
| 12/01/2010 | CN101897953A Non-invasive high-penetrability epidermal growth factor and application thereof |
| 12/01/2010 | CN101897952A Application of trefoil factor 3 to preparing medicament for preventing and/or treating depressive disorder |
| 12/01/2010 | CN101897936A Traditional Chinese medicinal preparation for treating mental disease and preparation method thereof |
| 12/01/2010 | CN101897931A Powder for dispelling mental stupefaction |
| 12/01/2010 | CN101897913A Formula of traditional Chinese medicine for treating prosopalgia |
| 12/01/2010 | CN101897887A Nourishing stomach-clearing agent |
| 12/01/2010 | CN101897885A Chinese medicinal pills for treating lingual retardation |
| 12/01/2010 | CN101897877A Traditional Chinese medicine for curing cerebral thrombosis |
| 12/01/2010 | CN101897843A New preparation of effective fractions of rhizoma acori graminei and preparation method thereof |
| 12/01/2010 | CN101897821A Granular preparation for promoting blood circulation, dredging collaterals and relieving pain and preparation method as well as quality control method thereof |
| 12/01/2010 | CN101897799A Drug composition with effect of improving sleep and preparation method thereof |
| 12/01/2010 | CN101897787A Essential oil for giving up smoking |
| 12/01/2010 | CN101897777A Traditional Chinese herbal medicine for treating cervical headache |
| 12/01/2010 | CN101897771A Medicine composition for preventing or treating neurasthenia |
| 12/01/2010 | CN101897764A Chinese medicinal preparation for treating sciatica |
| 12/01/2010 | CN101897762A Traditional Chinese medicine composition for treating schizophrenia |
| 12/01/2010 | CN101897749A Chinese medicinal external and oral preparations for treating facial paralysis |
| 12/01/2010 | CN101897746A Composite used for relieving alcoholic intoxication and protecting liver and preparation method and application thereof |
| 12/01/2010 | CN101897738A Application of actinidia kolomicta leaf flavonoids to preparing medicines for preventing and treating vascular dementia |
| 12/01/2010 | CN101897724A Method for producing a soft tissue filler and method for producing an adipose tissue transplant |
| 12/01/2010 | CN101897706A Composition containing folic acid and B vitamins and applications thereof |
| 12/01/2010 | CN101897698A Sugar-lowering drug composition containing vildagliptin and B vitamins and application thereof |
| 12/01/2010 | CN101897697A Sugar-lowering drug composition and application |
| 12/01/2010 | CN101897696A Sugar-lowering drug composition and application thereof |
| 12/01/2010 | CN101897675A Solid oral medicinal composition containing valsartan or pharmaceutically acceptable salts of valsartan |
| 12/01/2010 | CN101897541A Chinese medicinal herb health care incense |
| 12/01/2010 | CN101530599B A pharmaceutical composition for treating mental depression |